CIBC World Market’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
CIBC World Market's IHE Position: Q2 2026 in Review
CIBC World Market opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 8,250 shares worth $817K. The stake represents ﹤0.01% of the portfolio and ranks #1064 among its holdings. This is a return to the name: CIBC World Market previously reported a position in IHE as recently as Q4 2024.
CIBC World Market first reported a position in IHE in Q1 2014 and has held it in 21 quarters since. The position peaked at $4.11M in Q3 2018. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- CIBC World Market held 8,250 shares of iShares US Pharmaceuticals ETF worth $817K as of Q2 2026.
- iShares US Pharmaceuticals ETF was a new CIBC World Market position in Q2 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1064 holding.
- CIBC World Market first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and has held it in 21 quarters since.
- CIBC World Market's iShares US Pharmaceuticals ETF position peaked at $4.11M in Q3 2018.
- 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.